Search

everythinglearnresearchcommunity

for

Search:↓

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Cancer prevention has advanced significantly, with some strategies proving successful.

ATP helps prevent skin damage from vandetanib by reducing stress.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Trigonella foenum-graecum seeds and Butea monosperma flowers help promote hair growth and reduce hair loss after chemotherapy.

Luteolin-loaded nanoformulations could improve cancer treatment by enhancing luteolin's effectiveness.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

RTA 408 cream protects mice from radiation skin damage.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Phenylpropanoid sucrose esters show potential as anticancer agents.